Latest Headlines

  1. Short Notice Auction: Solid Dose Equipment For CMO, CDMO Operations 7/18/2025

    Federal Equipment Company is hosting a short notice auction featuring essential pharmaceutical solid dose equipment—ideal for contract manufacturers and development organizations (CMOs & CDMOs). This auction runs from July 25-30, 2025 and offers premium assets to support formulation, scale-up, and production workflows.

  2. GenesisM Breaks Ground On 154,000 Square Foot Biomanufacturing Facility In Greater Boston Area 7/18/2025

    GenesisM, a joint venture between Bain Capital Real Estate ("Bain Capital") and Botanic Properties ("Botanic"), today announced the official groundbreaking of its 154,000-square-foot Class A biomanufacturing facility at 45 Crosby Drive in Bedford, Massachusetts. The groundbreaking ceremony was attended by members of the project team, town officials and representatives, and local partners in the biotech and real estate communities.

  3. FDA Publishes 200+ CRLs For Increased Transparency 7/16/2025

    The letters were made available to increase transparency and help sponsors reduce similar mistakes in the future.

  4. Packaging And Process Equipment Auction Announced 7/7/2025

    Are you looking to upgrade your packaging line or start a new one without breaking the bank? Don’t miss the Proxio Group – “Processing & Packaging Equipment for Multiple Industrial Applications” auction hosted on BidSpotter, with lots closing July 23, 2025, at 10:30 am ET in Cleveland, OH.

  5. InQuest Science Seeking Business Development Executive To Promote Software Technologies 7/3/2025

    Actively looking for an energetic, self starter to lead our outside sales team for our software company, specializing in the visual inspection industry. Identifying and securing new customers leads in a growing industry. We’re looking for a results-driven sales representative to actively seek out and engage customer prospects.

  6. Riverarch Equity Partners Announce Acquisition Of Alconox By Portfolio Company TCP Analytical 7/3/2025

    Riverarch Equity Partners (“Riverarch”) and other investors, including Audax Strategic Capital, The Hillman Company, Lacy Diversified, and PPM America, together with their portfolio company TCP Analytical are pleased to announce the acquisition of Alconox, LLC (“Alconox” or the “Company”), a leading provider of branded laboratory cleaning solutions.

  7. CAI And ValGenesis Partner To Deliver AI-Enabled Digital Validation For The Life Sciences Industry 7/1/2025

    CAI, a global professional services firm specializing in operational readiness for regulated industries, today announced a strategic partnership with ValGenesis, Inc., a leader in digital validation lifecycle management. Together, the companies will help life sciences organizations modernize validation processes and improve compliance through the power of artificial intelligence. 

  8. Lab Oversupply Is Pushing Leasing, Rent and Relocation Down 7/1/2025

    The landscape of the U.S. pharmaceutical lab market is changing, according to JLL’s U.S. Life Sciences Property Report. In addition to the effort to bring pharma manufacturing back to the U.S. ahead of looming tariffs, an oversupply of space and lower tenant demand in large biopharma markets is dropping leasing rates, rent costs and lease duration, among other changes.

  9. Blue Mountain Launches Spring 2025 RAM Release, Advancing Asset Management For Life Sciences 6/25/2025

    Blue Mountain, the leader in GMP-compliant Enterprise Asset Management (EAM) software for life sciences, announces the launch of its Spring 2025 RAM Release, introducing advanced capabilities that drive operational excellence, maximize compliance, and empower mobile teams across the Life Sciences industry. 

  10. AGC Biologics Expands Cell Therapy Development Operations To Asia To Serve Growing Market Need 6/25/2025

    Today, we announced we will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc.’s Yokohama Technical Center, marking the latest step in the global expansion of the company’s Global Cell and Gene Technologies Division. The improved geographical footprint allows AGC Biologics to better serve customers requiring autologous and allogeneic products across all markets, with cell therapy manufacturing now available in three continents (Milan, Italy – Longmont, Colorado, U.S. – Yokohama, Japan).